Leica Biosystems

Leica Biosystems
Subsidiary GmbH
Industry Biotechnology, Digital pathology
Founded 1989
Headquarters Wetzlar, Germany
Key people
Matthias Weber – President; Gert Schaumberg – Vice President Finance CFO
Products Microtome; Cryostat; Vibratome
Parent Danaher Corporation
Website www.leicabiosystems.com

Leica Biosystems (founded 1989) is a Medical Devices company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company and a division of Danaher Corporation.

Company Description

The company has headquarters in Germany with operations in the United Kingdom, Australia, China, Singapore, Netherlands, California, Illinois, and Boston. A research and development facility concentrating on companion diagnostics for cancer drugs has been in operation in Danvers, Massachusetts since August 2012.[1]

The Massachusetts facility partners with Galena Biopharma to develop companion diagnostics for a breast cancer vaccine.[2]

Leica Biosystems acquired Aperio, an ePathology solutions company, in October 2012.[3] In October 2014, the company announced they were purchasing Devicor Medical Products, which is headquartered in Cincinnati and makes medical devices used in breast biopsies.[4]

The company partners with Mayo Clinic’s Department of Laboratory Medicine and Pathology in developing cytogenetics imaging software.[5]

References

  1. Seiffert, Don. “Leica Biosystems plans to expand R&D facility in Mass.” Boston Business Journal. Feb. 1, 2013
  2. Weintraub, Karen. “Leica Biosystems plans R&D expansion in area.” The Boston Globe. Feb. 25, 2013
  3. “Leica Biosystems completes acquisition of Aperio.” Yahoo Finance. Oct. 24, 2012
  4. Collins, Allison. “Leica Biosystems Adds GTCR-Backed Devicor Medical Products.” Mergers and Acquisitions. Oct. 28, 2014
  5. “Leica Biosystems and Mayo Clinic Collaborate on Future of Cytogenetics Imaging.” Mayo Clinic Blog. December 15, 2014


This article is issued from Wikipedia - version of the Tuesday, February 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.